secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001104659-23-130486
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Anthony Rimac to resign Jan. 31, 2024; interim appointments from Stout
--------------------------------------------------------------------------

- CFO Anthony Rimac resigns effective Jan. 31, 2024 for personal reasons; no disagreement with company or auditors.
- Stout's Gaeton Biscardi named Interim VP of Finance; Joe Oriti to serve as consultant and likely Interim Principal Financial Officer.
- Board intends to appoint Oriti as Interim PFO and will conduct a search for a permanent CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/tm2333876d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-130486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer